Avatar for Pear Therapeutics

Changing the game of therapeutics by taking them digital. Online therapy for opioid addiction

Changing the game of therapeutics by taking them digital. Online therapy for opioid addiction

Pear Therapeutics is the leader in prescription digital therapeutics. We aim to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurological conditions. Our lead product, reSET®, treats Substance Use Disorder and was the first prescription digital therapeutic to receive marketing authorization from the FDA to treat disease. Pear’s second product, reSET-O™, for the treatment of Opioid Use Disorder, received marketing clearance from the FDA in December 2018. For more information, visit us at peartherapeutics.com.
image
Total raised

$134M

Funded over

4 rounds

Latest round

Series C (Jan 2019)